XML 13 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Noncontrolling Interest
Beginning Balance at Dec. 31, 2023 $ 308,278 $ 14 $ 1,452,502 $ 215 $ (1,144,332) $ (121)
Beginning Balance, Shares at Dec. 31, 2023   145,082,271        
Issuance of common stock for cash upon exercise of stock options 44   44      
Issuance of common stock for cash upon exercise of stock options, Shares   30,900        
Vesting of restricted stock units, net   2,255,153        
Share-based compensation expense 14,298   14,298      
Other comprehensive loss (321)     (321)    
Net (loss) income (47,533)       (47,507) (26)
Ending Balance at Mar. 31, 2024 274,766 $ 14 1,466,844 (106) (1,191,839) (147)
Ending Balance, Shares at Mar. 31, 2024   147,368,324        
Beginning Balance at Dec. 31, 2024 202,485 $ 14 1,506,353 166 (1,303,824) (224)
Beginning Balance, Shares at Dec. 31, 2024   147,773,744        
Issuance of common stock for cash upon exercise of stock options $ 5,451 $ 1 5,450      
Issuance of common stock for cash upon exercise of stock options, Shares 882,493 882,493        
Vesting of restricted stock units and market-based restricted stock units   3,260,485        
Share-based compensation expense $ 12,147   12,147      
Other comprehensive loss (32)     (32)    
Net (loss) income (29,830)       (29,852) 22
Ending Balance at Mar. 31, 2025 $ 190,221 $ 15 $ 1,523,950 $ 134 $ (1,333,676) $ (202)
Ending Balance, Shares at Mar. 31, 2025   151,916,722